Parenteral nutrition-associated liver disease;Complicaciones hepáticas asociadas al uso de nutrición parenteral

Nutricion Hospitalaria

Volumn 23, Issue SUPPL. 2, 2008, Pages 25-33

  Moreno Villares, J M ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Cholestasis; Lipids; Liver; Newborns; Parenteral nutrition

Indexed keywords

CHOLINE; LIVER ENZYME; TAURINE;

DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; PARENTERAL NUTRITION; PREVALENCE; REVIEW; RISK FACTOR;

AGE FACTORS; CHOLAGOGUES AND CHOLERETICS; CHOLESTASIS; ENTERAL NUTRITION; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LIVER DISEASES; PARENTERAL NUTRITION; RISK FACTORS; SHORT BOWEL SYNDROME; TIME FACTORS; URSODEOXYCHOLIC ACID;

EID: 46749106817     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. Peden VH, Witzleben CL, Skelton MA. Total parenteral nutrition. J Pediatr 1971; 78:180-1.
2. Btaiche IF, Khalidi N. Metabolic complications of parenteral nutrition in adults, part 2. Am J Health Syst Pharm 2004; 61: 2050-9.
3. Fisher RL. Hepatobiliary abnormalities associated with total parenteral nutrition. Gastroenterol Clin N Am 1989; 18:645-66.
4. Merritt RJ. Cholestasis associated with total parenteral nutrition. J Pediatr Gastroenterol Nutr 1986; 5:9-22.
5. Teitelbaum DH. Parenteral nutrition-associated cholestasis. Curr Opin Pediatr 1997; 9:170-5.
6. Ukleja A, Romano MM. Complications of parenteral nutrition. Gastroenterol Clin N Am 2007; 36:23-46.
7. Colomb V, Goulet O, De Potter D, Ricour C. Liver disease associated with long-term parenteral nutrition in children. Transpl Proc 1994; 26:1467.
8. Quigley EMM, Marsh MN, Shaffer JL, Markin RS. Hepatobiliary complications of total parenteral nutrition. Gastroenterology 1993; 104:286-301.
9. Kelly DA. Liver complications of pediatric parenteral nutrition: epidemiology. Nutrition 1998; 14:153-7.
10. Salvino R, Ghanta R, Seidner DL, Mascha E, Xu Y, Steiger E. Liver failure is uncommon in adults receiving long-term parenteral nutrition. J Parent Enteral Nutr 2006; 30:202-8.
11. Baker AL, Rosenberg IH. Hepatic complications of total parenteral nutrition. Am J Med 1987; 82:489-97.
12. Das JB, Cosentino CM, Levy MF, Ansari GG, Raffensperger JG. Early hepatobiliary dysfunction during total parenteral nutrition: an experimental study. J Pediatr Surg 1993; 28:14-8.
13. Nanji AA, Anderson FH. Sensitivity and specificity of liver function tests in the detection of parenteral nutrition-associated cholestasis. J Parent Enteral Nutr 1985; 9:307-8.
14. Roberston JFR, Garden OJ, Shenkin A. Intravenous nutrition and hepatic dysfunction. J Parent Enteral Nutr 1986; 10:172-6.
15. Clarke PJ, Ball MJ, Kettlewell MG. Liver function tests in patients receiving parenteral nutrition. J Parent Enteral Nutr 1991; 15:54-9.
16. Abad-Lacruz A, González-Huix F, Esteve M, Fernández- Bañares F, Cabré E, Boix J y cols. Liver function test abnormalities in patients with inflammatory bowel disease receiving artificial nutrition: a prospective randomized study of total enteral nutrition vs total parenteral nutrition. J Parent Enteral Nutr 1990; 14:618-21.
17. Pallarés R, Sitges-Serra A, Fuentes J, Jaurrieta E, Guardia J, Fernández-Nogués F, Sitges-Creus A. Factores etiopatogé nicos posiblemente implicados en la disfunción hepática asociada a la nutrición parenteral: estudio prospectivo en 104 pacientes adultos. Med Clin (Barc) 1984; 83:832-6.
18. Grau T, Bonet A, Rubio M y cols. Liver dysfunction associated with artificial nutrition in critically ill patients. Crit Care 2007; 11: R10 (doi:10.1186/cc5670)
19. Black DD, Suttle EA, Whitington DF, Whitington GL, Korones SD. The effect of short-term total parenteral nutrition in hepatic function in the human neonate: a prospective randomized study demonstrating alteration of hepatic canalicular function. J Pediatr 1981; 99:445-9.
20. Bell RL, Ferry GD, Smith EO, Shulman RJ, Christensen BL, Labarthe DR, Wills CA. Total parenteral nutrition-related cholestasis in infants. J Parent Enteral Nutr 1986; 10:356-9.
21. Moreno Villares JM, Gomis Muñoz P, Galiano Segovia MJ, Valero Zanuy MA, Serrano Garrote O, León Sanz M. Complicaciones hepáticas asociadas a nutrición parenteral de corta duración en niños. An Esp Pediatr 1999; 51:22-6.
22. Kumpf VJ. Parenteral nutrition-associated liver disease in adult and pediatric patients. NCP 2006; 21:279-90.
23. Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000; 132:525-32.
24. Sondheimer JM; Asturias E, Cadnapaphornchai M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 1988; 27:131-7.
25. Suita S, Masumoto K, Yamanouchi T, Nagano M, Nakamura M. Complications in neonates with short bowel syndrome and long-term parenteral nutrition. J Parent Enteral Nutr 1999; 23(Supl. 5):S106-9.
26. Misra S, Ament ME, Vargas JH, Skoff C, Reyen L, Herzog F. Chronic liver disease in children on long-term parenteral nutrition. J Gastroenterol Hepatol 1996; 11:S4-S6.
27. Kubota A, Yonekura T, Hoki M y cols. Total parenteral nutrition-associated intrahepatic cholestasis in infants: 25 years' experience. J Pediatr Surg 2000; 35:1049-51.
28. Zambrano E, El-Hennawy M, Ehrekranz RA, Zelterman D, Reyes-Múgica M. Total parenteral nutrition induced liver pathology: an autopsy series of 24 newborn cases. Pediatr Dev Pathol 2004; 7:425-32.
29. Degott C, Messing B, Moreau D y cols. Liver phospholipidosis induced by parenteral nutrition: histologic, histochemical, and ultraestructural investigations. Gastroenterology 1988; 95: 183-91.
30. Fong DG, Nehra V, Lindor K y cols. Metabolic and nutritional considerations in nonalcoholic fatty liver. Hepatology 2000; 32:3-10.
31. Craig RM, Neumann T, Jeejeebhoy KN y cols. Severe hepatocellular reaction resembling alcoholic hepatitis with cirrhosis after massive small bowel resection and prolonged total parenteral nutrition. Gastroenterology 1980; 79:131-7.
32. Baker AL, Rosenberg IH. Hepatic complications of total parenteral nutrition. Am J Med 1987; 82:489-97.
33. Wolfe BM, Walter BK, Shaul DB, Wong L, Ruebner BH. Effect of total parenteral nutrition on hepatic histology. Arch Surg 1988; 123:1084-90.
34. Balistreri WF, Bove KE. Hepatobiliary consequences of parenteral alimentation. Progress in Liver Disease 1990; 9:567-601.
35. Kelly DA. Intestinal failure-associated liver disease: what do we know today. Gastroenterology 2006; 130:S70-S77.
36. Btaiche IF, Khalidi N. Parenteral Nutrition-associated liver complications in children. Pharmacothearapy 2002; 22:188-211.
37. Forchielli ML, Walker WA. Nutritional factors contributing to the development of cholestasis during total parenteral nutrition. Adv Pediatr 2003; 50:245-67.
38. Shaffer JL. Hepatic complications of parenteral nutrition. Clin Nutr 1995; 14:S59-S64.
39. Rovira Guasch R, Raventós Estellè A, Martí-Henneberg R, Closa Monasterolo R. Afectación hepática por nutrición parenteral en recién nacidos prematuros. An Esp Pediatr 1997; 47: 528-30.
40. Beale EF, Nelson RM, Bucciarelli RL, Donnelly WH, Eitzman DV. Intrahepatic cholestasis associated with parenteral nutrition in premature infants. Pediatrics 1979; 64:342-7.
41. Beath SV, Papadopoulo DA, Khan AR, Buick RG, Corkery JJ, Gornall P, Booth IW. Parenteral nutrition-related cholestasis in post surgical neonates: multivariate analysis of risk factors. J Pediatr Surg 1996; 31:604-6.
42. Hermans D, Talbotec C, Lacaille F, Goulet O, Ricour C, Colomb V. Early central catheter infections may contribute to hepatic fibrosis in children receiving long-term parenteral nutrition. JPGN 2007; 44:459-63.
43. Wu PA, Kerner JA, Berquist WE. Parenteral nutrition-associated cholestasis related to parental care. NCP 2006; 21:291-5.
44. Ito Y, Shils M. Liver dysfunction associated with long-term total parenteral nutrition in patients with massive bowel resection. J Parent Enteral Nutr 1991; 15:271-6.
45. Meehan JJ, Georgeson KE. Prevention of liver failure in parenteral nutrition-dependent children with short bowel syndrome. J Pediatr Surg 1997; 32:473-5.
46. Beau P, Barrioz T, Ingrand P. L'hépatopathie cholestatique de la nutrition parentérale totale est-elle une maladie infectieuse? Gastroenterol Clin Biol 1994; 18:63-7.
47. Riordan SM, McIver CJ, Willimas R. Liver damage in human small intestinal bacterial overgrowth. Am J Gastroenterol 1998; 93:234-7.
48. Van Saene HFK, Taylor N, Donnell SC y cols. Gut overgrowth with abnormal flora: the missing link in parenteral nutrition-related sepsis in surgical neonates. Eur J Clin Nutr 2003; 57: 548-53.
49. Zamir O, Nussbaum MS, Bhadra S, Subbiah MTR, Rafferty JF, Fischer JE. Effect of enteral feeding on hepatic steatosis induced by total parenteral nutrition.J Parent Enteral Nutr 1994; 18:20-5.
50. Hofmann AF. Defective biliary secretion during total parenteral nutrition: probable mechanisms and possible solutions. JPGN 1995; 20:376-90.
51. Sokol RJ, Murria K, Boyd J y cols. Comparative proteomic analysis of parenteral nutrition-associated liver disease (PNALD) in infants with intestinal failure. Hepatology 2007; 46(4 Supl. 1):278A.
52. Wang H, Khaoustov VI, Krishnan B, Cai W, Stoll B, Burrin DG, Yoffe B. Total parenteral nutrition induces liver steatosis and apoptosis in neonatal piglets. J Nutr 2006; 136:2547-52.
53. Messing B, Colombel JF, Herebach D, Chazouillères O, Galian A. Chronic cholestasis and macronutrient excess in patients treated with prolonged parenteral nutrition. Nutrition 1992; 8:30-6.
54. Buchmiller CE, Kleiman-Wexler RL, Ephgrave KS, Booth B, Hensley CE. Liver dysfunction and energy source: results of a randomized clinical trial.J Parent Enteral Nutr 1993; 17:301-6.
55. Blau J, Sridhar S, Mathieson S, Chawla A. Effects of protein/nonprotein caloric intake on parenteral nutrition-associated cholestasis in premature infants weighing 600-1,000 grams. J Parent Enteral Nutr 2007; 31:487-90.
56. Moss RL, Das JB, Ansari G, Raffensperger JG. Hepatobiliary dysfunction during total parenteral nutrition is caused by infusate, not the route of administration. J Pediatr Surg 1993; 28: 391-7.
57. Fell JME, Reynolds AP, Meadows N y cols. Manganese toxicity in children receiving long-term parenteral nutrition. Lancet 1996; 347:1218-21.
58. Whalen GF, Shamberger RC, Pérez-Atayde A, Folkman J. A proposed cause for the hepatic dysfunction associated with parenteral nutrition. J Pediatr Surg 1990; 25:622-6.
59. Rudman D, Williams PJ. Nutrient deficiencies during total parenteral nutrition. Nutr Reviews 1985; 43:1-13.
60. Buchman AL, Dubin MD, Moukarzel AA y cols. Choline deficiency: a cause of hepatic stetosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology 1995; 22:1399-403.
61. Misra S, Ahn C, Ament ME y cols. Plasma choline concentrations in children requiring long-term home parenteral nutrition: a case control study. J Parent Enteral Nutr 1999; 23:305-8.
62. Buchman A. Choline deficiency during parenteral nutrition in human. NCP 2003; 18:353-8.
63. Clayton PT, Whitfield P, Iyer K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition 1998; 14:158-6
64. Clayton PT, Bowron A, Mills KA, Massoud A Casteels M, Milla J. Phytosteroloemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology 1993; 105:186-13.
65. Messing B, Bories C, Klunstlingerr F, Bernier JJ. Does total parenteral nutrition induce gallbladder sludge formation and lithiasis? Gastroenterology 1983; 84:1012-19.
66. Klein S, Nealon WH. Hepatobiliary abnormalities associated with total parenteral nutrition. Sem Liver Dis 1988; 8:237-46.
67. Pacífico L, Celestre Mi, Ananay C, Palantonio P, Chiesa C, Laghi A. MRI and ultrasound for hepatic fat quantification: relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease. Acta Paediatr 2007; 96:542-7.
68. Bueno J, Ohwada S, Kocoshis S y cols. Factors impacting the survival of children with intestinal failure referred for intestinal transplantation. J Pediatr Surg 1999; 34:27-33.
69. Nasr A, Avitzur Y, Ng VL, De Silva N, Wales PW. The use of conjugated hiperbilirubinemia greater than 100 μmol/L as an indicator of irreversible liver disease in infants with short bowel syndrome. J Pediatr Surg 2007; 42:359-62.
70. Christensen RD, Henry E, Wiedmeier SE, Burnett J, Lambert DK. Identifying patients, on the first day of life, at high risk of developing parenteral nutrition-associated liver disease. J Perinatol 2007; 1-7.
71. Dahms BB, Halpin TC. Serial liver biopsies in parenteral nutrition associated cholestasis in early infancy. Gastroenterology 1981; 81:136-44.
72. Howard L, Ashley C. Management of complications in patients receiving home parenteral nutrition. Gastroenterology 2003; 124:1651-61.
73. Carter BA, Karpen SJ. Intestinal failure-associated liver disease: management and treatment strategies past, present, and future. Sem Liver Dis 2007; 27:251-7.
74. Messing B, Zarka Y, Lémman M, Iglicki F, Coffin B, Rambaud J. Chronic cholestasis associated with long-term parenteral nutrition. Transplant Proc 1994; 26:148-9.
75. Burstyne M, Jensen G. Abnormal liver functions as a result of total parenteral nutrition in a patient with short-bowel syndrome. Nutrition 2000; 16:1090-2.
76. th PENSA Congress, 97-102.
77. Shin J, Namgung R, Park MS, Lee C. Could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates? Eur J Pediatr 2008; 167:197-202.
78. Beau P, Labat-Labourdette J, Ingrand P, Beauchant M. Is Ursodeoxycholic acid an effective therapy for total parenteral nutrition related liver disease? J Hepatol 1994; 20:240-4.
79. Arslanoglu S, Moro GE, Tauschel HD, Boehm G. Ursodeoxycholic acid treatment in preterm infants: a pilot study for the prevention of cholestasis associated with total parenteral nutrition. JPGN 2008; 46:228-31.
80. Lindor KD, Burnes J. Ursodeoxycholic acid for the treatment of home parenteral nutrition-associated cholestasis. Gastroenterology 1991; 101:250-3.
81. Spagnoulo MI, Iorio R, Vegnente A, Guarino A. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study. Gastroenterology 1996; 111:716-9.
82. Chen CY, Tsao PN, Chen HL, Chou HC, Hsieh WS, Chang MH. Ursodeoxycholic acid (UDCA) therapy in very low birth weight infants with parenteral nutrition-associated cholestasis. J Pediatr 2004; 145:317-21.
83. Balistreri W. Bile acid therapy in pediatric hepatobiliary disease: the role of Ursodeoxycholic acid. JPGN 1997; 24:573-89.
84. Rubin RA, Kowalski TE, Khandelwal M, Malet PF. Ursodiol for hepatobiliary disorders. Ann Intern Med 1994; 121:207-18.
85. Schwartz JB, Merritt RJ, Rosenthal P, Diament M, Sinatra FR, Ramos A. Ceruletide to treat neonatal cholestasis. Lancet 1988; 1219.
86. Teitelbaum DH, Han-Markey T, Dronowski RA y cols. Use of cholecystokinin to prevent the development of parenteral nutrition-associated cholestasis. J Parent Enteral Nutr 1997; 21:100-3.
87. Rintala RJ, Pohjavouri M. Total parenteral nutrition-associated cholestasis in surgical neonates may be reversed by intravenous cholecystokinin: a preliminary report. J Pediatr Surg 1995; 30:827-30.
88. Curran TJ, Uzoaru I, Das JB, Ansari G, Raffensperger JG. The effect of cholecystokinin-octapeptide on the hepatobiliary dysfunction caused by total parenteral nutrition. J Pediatr Surg 1995; 30:242-5.
89. Teitelbaum DH, Han-Markey T, Schumacher RE. Treatment of parenteral nutrition-associated cholestasis with cholecystokinin-octapeptide. J Pediatr Surg 1995; 30:1082-5.
90. Doty JE, Pitt HA, Porter-Fink V, Denuesten L. Cholecystokinin prophylaxis of parenteral nutrition-induced gallbladder disease. Ann Surg 1985; 201:76-80.
91. Sitzmann JV, Pitt HA, Steinborn PA, Pasha ZR, Sanders RC. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans. Surg Gyn Obst 1990; 170:25-31.
92. Paauw JD, Davis AT. Taurine concentrations in serum of critically injured patients and age- and sex-matched healthy control subjects. Am J Clin Nutr 1990; 52:657-60.
93. Kopple JD, Vinton NE, Laidlaw SA, Ament ME. Effect of intravenous taurine supplementation on plasma blood cell, and urine taurine concentrations in adults undergoing long-term parenteral nutrition. Am J Clin Nutr 1990; 52:846-53.
94. Salas Martínez J, Morán Penco JM, Maciá Botejara E, Vinagre Velasco LM. Colestasis asociada a nutrición parenteral: influencia de las dietas exentas de taurina y de sus precursores metabólicos sobre la composición biliar y la estructura hepá-tica. Nutr Hosp 1994; 9:44-53.
95. Guertin F, Roy CC, Lepage G y cols. Effect of taurine on total parenteral nutrition-associated cholestasis. JPEN 1991; 15: 247-51.
96. Dorvil NP, Yousef IM; Tuchweber B, Roy CC. Taurine prevents cholestasis induced by lithocholic acid sulphate in guinea pigs. Am J Clin Nutr 1983; 37:221-32-.
97. Geggel HS, Ament ME, Heckenlively JR, Martin DA, Koppl JD. Nutritional requirement for taurine in patients receiving long-term parenteral nutrition. N Engl J Med 1985; 312:142-6.
98. Helms RA, Storm MC, Christensen ML, Hak EB, Chesney RW. Cysteine supplementation results in normalization of plasma taurine concentrations in children receiving home parenteral nutriton. J Pediatr 1999; 134:358-61.
99. Spencer AU, Yu S, Tracy TF y cols. Parenteral nutrition-associated cholestasis in neonates: multivariate analysis of the potential protective effect of taurine. J Parent Enteral Nutr 2005; 29:337-44.
100. Schneider SM, Joly F, Gehrardst MF y cols. Taurine status and response to intravenous taurine supplementation in adults with short-bowel syndrome undergoing long-term parenteral nutrition: a pilot study. Br J Nutr 2006; 96:365-70.
101. Gura KM, Duggan CP, Collier SB y cols. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 2006; 118:e197-e201.
102. Demircan M, Uguralp S, Mutus M y cols. The effects of acetylsalicylic acid, Interferon-α, and vitamin E on prevention of parenteral nutrition-associated cholestasis: an experimental study. JPGN 1999; 28:291-5.
103. Forrest EH, Oien KA, Dickson S, Galloway D, Mills PR. Improvement in cholestasis associated with total parenteral nutrition after treatment with an antibody against tumour necrosis factor alpha. Liver 2002; 22:317-20.
104. Abi-Hanna A, Mattis LE, Chao C, Conner K, Saavedra JJ. Resolution of TPN associated cholestasis following discontinuation of parenteral protein. JPGN 1996; 23:352.
105. NG PC, Lee CH, Wong SPS y cols. High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants. Gastroenterology 2007; 132: 1726-39.
106. Muiesan P, Dhawan A, Novelli M, Mieli-Vergani G, Rel M, Heaton ND. Isolated liver transplant and sequential small bowel transplantation for intestinal failure and related liver disease in children. Transplantation 2000; 11:2323-6.
107. Barshes NR, Carter BA, Karpen SJ, O'Mahony CA, Goss JA. Isolated orthotopic liver transplantation for parenteral nutrition-associated liver injury. J Parent Enteral Nutr 2006; 30:526-9.
108. Chungfat N, Dixler I, Cohran V y cols. Impact of parenteral nutrition-associated liver disease on intestinal transplant waitlist dynamics. J Am Coll Surg 2007; 205:755-61.